SGLT-2 inhibitors for inhibiting the Progression of chronic Kidney Disease

被引：1
作者：
Heine, Gunnar Henrik [1 ]
机构：
[1] AGAPLESION MARKUS KRANKENHAUS, Med Klin 2, Wilhelm Epstein Str 4, D-60431 Frankfurt, Germany
来源：
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT | 2020年 / 145卷 / 11期
关键词：
NEPHROPATHY; IRBESARTAN;
D O I：
10.1055/a-1163-7590
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：762 / 766
页数：5
相关论文
共 50 条
[21]   SGLT2 inhibitors and NLRP3 inflammasome: potential target in diabetic kidney disease [J].
Machado Junior, Paulo Andre Bispo ;
Lass, Andre ;
Pilger, Bruna Isadora ;
Fornazari, Raphaella ;
de Moraes, Thyago Proenca ;
Pinho, Ricardo Aurino .
JORNAL BRASILEIRO DE NEFROLOGIA, 2024, 46 (04)
[22]   Renal intrinsic cells remodeling in diabetic kidney disease and the regulatory effects of SGLT2 Inhibitors [J].
Guo, Wenwen ;
Li, Han ;
Li, Yixuan ;
Kong, Wen .
BIOMEDICINE & PHARMACOTHERAPY, 2023, 165
[23]   Barriers to initiating SGLT2 inhibitors in diabetic kidney disease: a real-world study [J].
Jeong, Su Jin ;
Lee, Seung Eun ;
Shin, Dong Hyun ;
Park, Ie Byung ;
Lee, Hui Seung ;
Kim, Kyoung-Ah .
BMC NEPHROLOGY, 2021, 22 (01)
[24]   Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy? [J].
Wolos-Klosowicz, Katarzyna ;
Matuszewski, Wojciech ;
Rutkowska, Joanna ;
Krankowska, Katarzyna ;
Bandurska-Stankiewicz, Elzbieta .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (20)
[25]   Gender, Albuminuria and Chronic Kidney Disease Progression in Treated Diabetic Kidney Disease [J].
Fernandez-Fernandez, Beatriz ;
Mahillo, Ignacio ;
Sanchez-Rodriguez, Jinny ;
Carriazo, Sol ;
Sanz, Ana B. ;
Sanchez-Nino, Maria Dolores ;
Ortiz, Alberto .
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (06)
[26]   "Dip" in eGFR: Stay the Course With SGLT-2 Inhibition [J].
Umanath, Kausik ;
Testani, Jeffrey M. ;
Lewis, Julia B. .
CIRCULATION, 2022, 146 (06) :463-465
[27]   The Embarrassment of Riches: Combining SGLT2 Inhibitors and Nonsteroidal Mineralocorticoid Antagonists for the Treatment of Diabetic Kidney Disease [J].
Haller, Hermann .
AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (08) :605-607
[28]   The role of interstitial changes in the progression of chronic kidney disease [J].
Sulikowska, Beata ;
Rutkowski, Boleslaw ;
Marszalek, Andrzej ;
Manitius, Jacek .
POSTEPY HIGIENY I MEDYCYNY DOSWIADCZALNEJ, 2015, 69 :830-837
[29]   The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors [J].
Weir, Matthew R. .
POSTGRADUATE MEDICINE, 2016, 128 (03) :290-298
[30]   Kidney Outcomes Associated With SGLT2 Inhibitors Versus Other Glucose-Lowering Drugs in Real-world Clinical Practice: The Japan Chronic Kidney Disease Database [J].
Nagasu, Hajime ;
Yano, Yuichiro ;
Kanegae, Hiroshi ;
Heerspink, Hiddo J. L. ;
Nangaku, Masaomi ;
Hirakawa, Yosuke ;
Sugawara, Yuka ;
Nakagawa, Naoki ;
Tani, Yuji ;
Wada, Jun ;
Sugiyama, Hitoshi ;
Tsuruya, Kazuhiko ;
Nakano, Toshiaki ;
Maruyama, Shoichi ;
Wada, Takashi ;
Yamagata, Kunihiro ;
Narita, Ichiei ;
Tamura, Kouichi ;
Yanagita, Motoko ;
Terada, Yoshio ;
Shigematsu, Takashi ;
Sofue, Tadashi ;
Ito, Takafumi ;
Okada, Hirokazu ;
Nakashima, Naoki ;
Kataoka, Hiromi ;
Ohe, Kazuhiko ;
Okada, Mihoko ;
Itano, Seiji ;
Nishiyama, Akira ;
Kanda, Eiichiro ;
Ueki, Kohjiro ;
Kashihara, Naoki .
DIABETES CARE, 2021, 44 (11) :2542-2551
12345